AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33676572 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain intervention (diet, exercise, cognitive training, and vascular risk management)
Number of subjects: 47
Study 33676572 — intervention group
Group type: COMPARATOR
Intervention: General health advice (control group)
Number of subjects: 47
Study 35688164 — intervention group
Group type: EXPERIMENTAL
Intervention: tixagevimab-cilgavimab 600 mg (two consecutive 3 mL intramuscular injections, 300 mg tixagevimab and 300 mg cilgavimab)
Number of subjects: 910
Study 35688164 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 910
Study 35688164 — intervention group
Group type: EXPERIMENTAL
Intervention: tixagevimab-cilgavimab 600 mg
Number of subjects: 910
Study 35251938 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week web-based self-help intervention
Number of subjects: 152
Study 35251938 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 152
Study 32334703 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg or 600 mg loading dose, then 75 mg once daily for 12 months)
Number of subjects: 1002
Study 32334703 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor (180 mg loading dose, then 90 mg twice daily for 12 months)
Number of subjects: 1002
Study 32334703 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 1002
Study 32334703 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor
Number of subjects: 1002
Study 36254029 — intervention group
Group type: EXPERIMENTAL
Intervention: Religious Rational Emotive Behavior Therapy (RREBT) for 12 weeks
Number of subjects: 67
Study 36254029 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 67
Study 32964915 — intervention group
Group type: EXPERIMENTAL
Intervention: Altruism frame emphasizing local impact
Number of subjects: 1267
Study 32964915 — intervention group
Group type: EXPERIMENTAL
Intervention: Altruism frame emphasizing national impact
Number of subjects: 1267
Study 32964915 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety induction
Number of subjects: 1267
Study 32964915 — intervention group
Group type: EXPERIMENTAL
Intervention: Compassion induction
Number of subjects: 1267
Study 32964915 — intervention group
Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 1267
Study 35412049 — intervention group
Group type: EXPERIMENTAL
Intervention: Full face mask
Number of subjects: 30
Study 35412049 — intervention group
Group type: EXPERIMENTAL
Intervention: Half mask
Number of subjects: 30
Study 35412049 — intervention group
Group type: EXPERIMENTAL
Intervention: Snorkelling mask
Number of subjects: 30
Study 33034015 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-gastric balloon (IGB) therapy
Number of subjects: 99
Study 35023284 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ART (n=477)
Number of subjects: 954
Study 35023284 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART (n=477)
Number of subjects: 954
Study 33491480 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture Tape (ST)
Number of subjects: 119
Study 33491480 — intervention group
Group type: COMPARATOR
Intervention: Modified Broström (MB)
Number of subjects: 119
Study 35888659 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 cmH2O of PEEP
Number of subjects: 52
Study 35888659 — intervention group
Group type: COMPARATOR
Intervention: Zero-PEEP (ZEEP)
Number of subjects: 52
Study 33228735 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative controls by general practitioners (GPs)
Number of subjects: 200
Study 33228735 — intervention group
Group type: COMPARATOR
Intervention: Postoperative controls by otolaryngologists
Number of subjects: 200
Study 34467969 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrexafungerp (300 mg twice for 1 day)
Number of subjects: 286
Study 34467969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 286
Study 33582019 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy
Number of subjects: 64
Study 33582019 — intervention group
Group type: COMPARATOR
Intervention: Control group (no convalescent plasma therapy)
Number of subjects: 64
Study 32410641 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at the lung meridian
Number of subjects: 48
Study 32410641 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at the heart meridian
Number of subjects: 48
Study 36261538 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri ATCC PTA 6475 supplementation
Number of subjects: 20
Study 33901921 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factors (G-CSF)
Number of subjects: 458
Study 33901921 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin
Number of subjects: 458
Study 32675553 — intervention group
Group type: EXPERIMENTAL
Intervention: Dome (n=29)
Number of subjects: 123
Study 32675553 — intervention group
Group type: EXPERIMENTAL
Intervention: dV-Trainer (n=30)
Number of subjects: 123
Study 32675553 — intervention group
Group type: EXPERIMENTAL
Intervention: DVSS (n=32)
Number of subjects: 123
Study 32675553 — intervention group
Group type: COMPARATOR
Intervention: Control (n=32)
Number of subjects: 123
Study 35592074 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilevel intervention (individual, interpersonal, and community levels)
Number of subjects: 0
Study 35592074 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 34157552 — intervention group
Group type: EXPERIMENTAL
Intervention: Perspective taking (actively imagining another person's mental states)
Number of subjects: 0
Study 34157552 — intervention group
Group type: COMPARATOR
Intervention: Control instructions
Number of subjects: 0
Study 35059803 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 kVp tube voltage, Smart mA for noise index (NI) of 36HU, contrast dose rate of 16mgI/kg/s, and DLIR-H
Number of subjects: 100
Study 35059803 — intervention group
Group type: COMPARATOR
Intervention: 120 kVp, Smart mA for NI of 25HU, contrast dose rate of 32mgI/kg/s, and 60% ASIR-V
Number of subjects: 100
Study 32034255 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face intervention group
Number of subjects: 124
Study 32034255 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 124
Study 32034255 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 124
Study 33915824 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement control exercise group
Number of subjects: 42
Study 33915824 — intervention group
Group type: COMPARATOR
Intervention: Muscle strengthening exercise group
Number of subjects: 42
Study 33915824 — intervention group
Group type: COMPARATOR
Intervention: Muscle balance exercise group
Number of subjects: 42
Study 33727377 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed cow's milk formula
Number of subjects: 0
Study 33727377 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-based formula
Number of subjects: 0
Study 33727377 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy-based formula
Number of subjects: 0
Study 33727377 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid-based formula
Number of subjects: 0
Study 32179212 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid fish oil emulsion (Om3)
Number of subjects: 60
Study 32179212 — intervention group
Group type: COMPARATOR
Intervention: Control oil emulsion (Om6)
Number of subjects: 60
Study 35987298 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic cognitive‐behavioral therapy (CBT) treatment
Number of subjects: 200
Study 35987298 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified (social anxiety) treatment
Number of subjects: 200
Study 34269262 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 0
Study 34269262 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 0
Study 33151330 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital CBT (Sleepio)
Number of subjects: 100000
Study 33151330 — intervention group
Group type: COMPARATOR
Intervention: No insomnia treatment
Number of subjects: 100000
Study 33151330 — intervention group
Group type: EXPERIMENTAL
Intervention: Group CBT
Number of subjects: 100000
Study 33151330 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy
Number of subjects: 100000
Study 33151330 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual CBT
Number of subjects: 100000
Study 34714175 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser + Stretch
Number of subjects: 215
Study 34714175 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo + Stretch
Number of subjects: 215
Study 34714175 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretch
Number of subjects: 215
Study 34714175 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser
Number of subjects: 215
Study 34714175 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 215
Study 33617181 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcostal anterior quadratus lumborum block
Number of subjects: 55
Study 33617181 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 55
Study 33617181 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient global assessment
Number of subjects: 55
Study 33617181 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of PACU stay
Number of subjects: 55
Study 33617181 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative duration of hospitalization
Number of subjects: 55
Study 35324419 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D model
Number of subjects: 118
Study 35324419 — intervention group
Group type: COMPARATOR
Intervention: 2D lecture
Number of subjects: 118
Study 32379474 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched snack (wakame and carob)
Number of subjects: 40
Study 32379474 — intervention group
Group type: COMPARATOR
Intervention: Control snack
Number of subjects: 40
Study 35926901 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-cTn above median (1.5 ng/L)
Number of subjects: 1796
Study 35926901 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 above median (1.8 ng/L)
Number of subjects: 1796
Study 35926901 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-cTn and IL-6 above median in participants with nonobstructive CAD (stenosis 1%-69%)
Number of subjects: 1796
Study 33559893 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib combined with doxorubicin‐etoposide‐methylprednisolone (Ru‐DEP) regimen
Number of subjects: 54
Study 32598468 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch plus nicotine gum (8 weeks)
Number of subjects: 416
Study 32598468 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch plus nicotine gum (26 weeks)
Number of subjects: 416
Study 32598468 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch plus gum (both groups)
Number of subjects: 416
Study 32598468 — intervention group
Group type: COMPARATOR
Intervention: Lapsers (vs. matched nonlapsers)
Number of subjects: 416
Study 32507328 — intervention group
Group type: EXPERIMENTAL
Intervention: Voiced High-Frequency Oscillation (VHFO)
Number of subjects: 30
Study 32507328 — intervention group
Group type: EXPERIMENTAL
Intervention: Lax Vox technique
Number of subjects: 30
Study 32507328 — intervention group
Group type: EXPERIMENTAL
Intervention: Both exercises (VHFO and Lax Vox)
Number of subjects: 30
Study 33922745 — intervention group
Group type: EXPERIMENTAL
Intervention: DFGG + Coronal Advancement Flap (CAF)
Number of subjects: 68
Study 33922745 — intervention group
Group type: COMPARATOR
Intervention: CTG + Coronal Advancement Flap (CAF)
Number of subjects: 68
Study 32738019 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glulisine (intervention group) for 6 months
Number of subjects: 14
Study 32738019 — intervention group
Group type: COMPARATOR
Intervention: Zinc-containing insulin (control group) for 6 months, then switched to insulin glulisine
Number of subjects: 14
Study 35688566 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of alcohol (measured by AUDIT score)
Number of subjects: 319
Study 35688566 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at first sexual intercourse
Number of subjects: 319
Study 35688566 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of onset of alcohol use
Number of subjects: 319
Study 35688566 — intervention group
Group type: EXPERIMENTAL
Intervention: AUDIT score
Number of subjects: 319
Study 34393260 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention combined with an intensive 6‐month cardiovascular exercise programme
Number of subjects: 38
Study 34393260 — intervention group
Group type: COMPARATOR
Intervention: Control group (postpartum women without pregnancy complications or known cardiovascular risk)
Number of subjects: 38
Study 34393260 — intervention group
Group type: COMPARATOR
Intervention: Reference group (postpartum women without pregnancy complications or known cardiovascular risk)
Number of subjects: 38
Study 33015813 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299v (2 x 10^10 CFU)
Number of subjects: 35
Study 33015813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 33368265 — intervention group
Group type: EXPERIMENTAL
Intervention: Probable bruxism
Number of subjects: 541
Study 33368265 — intervention group
Group type: COMPARATOR
Intervention: Periodontitis
Number of subjects: 541
Study 33066107 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis (BPL1)
Number of subjects: 39
Study 33066107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 33945163 — intervention group
Group type: EXPERIMENTAL
Intervention: One-session AS cognitive concerns intervention
Number of subjects: 72
Study 33945163 — intervention group
Group type: COMPARATOR
Intervention: Single health information control session
Number of subjects: 72
Study 34474715 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced Oscillation Technique (FOT)
Number of subjects: 162
Study 34474715 — intervention group
Group type: COMPARATOR
Intervention: Aerosol Provocation System (APS) dosimeter method
Number of subjects: 162
Study 34694877 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir plus 2 nucleoside reverse transcriptase inhibitors
Number of subjects: 314
Study 34694877 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir-boosted lopinavir
Number of subjects: 314
Study 34254654 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold application
Number of subjects: 96
Study 34254654 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat application
Number of subjects: 96
Study 34254654 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study 34587567 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS) to the cerebellar midline, administered 5 times/week for 2 weeks.
Number of subjects: 64
Study 34587567 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control group).
Number of subjects: 64
Study 32405757 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (7 mg/24 h transdermally)
Number of subjects: 26
Study 32405757 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg p.o., body weight-adjusted)
Number of subjects: 26
Study 32405757 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine plus Propranolol
Number of subjects: 26
Study 32405757 — intervention group
Group type: COMPARATOR
Intervention: Double-placebo
Number of subjects: 26
Study 32405757 — intervention group
Group type: COMPARATOR
Intervention: Nicotine only
Number of subjects: 26
Study 32405757 — intervention group
Group type: COMPARATOR
Intervention: Propranolol only
Number of subjects: 26
Study 34192885 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolperisone administered orally three-times daily for 14 days
Number of subjects: 1000
Study 34192885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 33518129 — intervention group
Group type: EXPERIMENTAL
Intervention: In ovo injection of organic microminerals (zinc, manganese, and copper)
Number of subjects: 108
Study 33518129 — intervention group
Group type: COMPARATOR
Intervention: Diluent only (control group)
Number of subjects: 108
Study 33518129 — intervention group
Group type: EXPERIMENTAL
Intervention: 0-hour holding time (HT)
Number of subjects: 108
Study 33518129 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour holding time (24HT)
Number of subjects: 108
Study 33518129 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall body temperature at hatch
Number of subjects: 108
Study 33518129 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall body temperature at 39 days of age
Number of subjects: 108
Study 33518129 — intervention group
Group type: EXPERIMENTAL
Intervention: General increase in body temperature during the grow out period
Number of subjects: 108
Study 32347765 — intervention group
Group type: EXPERIMENTAL
Intervention: LPG stoves
Number of subjects: 800
Study 32347765 — intervention group
Group type: COMPARATOR
Intervention: Biomass burning cookstoves
Number of subjects: 800
Study 32347765 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adult women
Number of subjects: 800
Study 35102808 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training (40‐60% heart rate reserve) and self‐management education for 30 minutes, three times a week for 8 weeks
Number of subjects: 119
Study 35102808 — intervention group
Group type: COMPARATOR
Intervention: Usual gait training
Number of subjects: 119
Study 34092026 — intervention group
Group type: COMPARATOR
Intervention: Whiteness without lamp (WHN)
Number of subjects: 40
Study 34092026 — intervention group
Group type: COMPARATOR
Intervention: Pola office without lamp (PON)
Number of subjects: 40
Study 34092026 — intervention group
Group type: EXPERIMENTAL
Intervention: Whiteness with lamp (WHL)
Number of subjects: 40
Study 34092026 — intervention group
Group type: EXPERIMENTAL
Intervention: Pola office with lamp (POL)
Number of subjects: 40
Study 34092026 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature increase (internal)
Number of subjects: 40
Study 34092026 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature increase (external)
Number of subjects: 40
Study 32579432 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month positive psychological intervention
Number of subjects: 155
Study 33279277 — intervention group
Group type: EXPERIMENTAL
Intervention: ALGINATE
Number of subjects: 113
Study 33279277 — intervention group
Group type: COMPARATOR
Intervention: NPWT
Number of subjects: 113
Study 35301345 — intervention group
Group type: EXPERIMENTAL
Intervention: ITknife nano
Number of subjects: 50
Study 35301345 — intervention group
Group type: COMPARATOR
Intervention: DualKnife
Number of subjects: 50
Study 33855796 — intervention group
Group type: EXPERIMENTAL
Intervention: PROGRESS + educational booklets
Number of subjects: 431
Study 33855796 — intervention group
Group type: COMPARATOR
Intervention: Educational booklets
Number of subjects: 431
Study 33855796 — intervention group
Group type: EXPERIMENTAL
Intervention: PROGRESS users
Number of subjects: 431
Study 33855796 — intervention group
Group type: EXPERIMENTAL
Intervention: PROGRESS non-users
Number of subjects: 431
Study 35794522 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMPT speech motor treatment (intensive 3 weeks period, twice-a-day administration)
Number of subjects: 60
Study 35794522 — intervention group
Group type: COMPARATOR
Intervention: Standard care (waitlist control group)
Number of subjects: 60
Study 33769017 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeon 1 (more than 20 years of experience)
Number of subjects: 135
Study 33769017 — intervention group
Group type: COMPARATOR
Intervention: Surgeon 2 and 3 (10 years of experience)
Number of subjects: 135
Study 33769017 — intervention group
Group type: EXPERIMENTAL
Intervention: CUSUM analysis
Number of subjects: 135
Study 33769017 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall complications
Number of subjects: 135
Study 32379333 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous corticosteroids
Number of subjects: 455
Study 32379333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 455
Study 36229537 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose triple combination polypill (telmisartan-20mg/amlodipine-2.5 mg/chlorthalidone-12.5 mg)
Number of subjects: 700
Study 36229537 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 700
Study 34378260 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% Pistacia atlantica ointment, applied topically three times a day for 8 weeks
Number of subjects: 60
Study 34378260 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment, applied topically three times a day for 8 weeks
Number of subjects: 60
Study 32250250 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided complete revascularisation
Number of subjects: 885
Study 32250250 — intervention group
Group type: COMPARATOR
Intervention: IRA-only treatment
Number of subjects: 885
Study 33618847 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancellous screws
Number of subjects: 91
Study 33618847 — intervention group
Group type: EXPERIMENTAL
Intervention: Sliding hip screw (SHS)
Number of subjects: 91
Study 33618847 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 4,000 IU
Number of subjects: 91
Study 33618847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 33618847 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 91
Study 33346518 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-7x concentrated PRP
Number of subjects: 20
Study 33346518 — intervention group
Group type: COMPARATOR
Intervention: 2-3x concentrated PRP
Number of subjects: 20
Study 32709430 — intervention group
Group type: EXPERIMENTAL
Intervention: Pranayama breathing exercise group (PBE-G; n = 15)
Number of subjects: 30
Study 32709430 — intervention group
Group type: COMPARATOR
Intervention: Conventional breathing exercise group (CBE-G; n = 15)
Number of subjects: 30
Study 32444038 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson's Relaxation Response (BRR) administered twice a day over 5 consecutive days
Number of subjects: 84
Study 32444038 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 84
Study 36274582 — intervention group
Group type: EXPERIMENTAL
Intervention: Tape on the thumb (T2)
Number of subjects: 11